Article

Systematic identification of drug-based prognostic biomarkersby integrating multiomics in breast cancer

2020-05-11

Abstract excerpt

<h4>Background: </h4> Drug repositioning plays an important role in the current drug research and development field, as the high cost and long period required to bring drugs into commerce are driving efforts to repurpose drugs approved by the U.S. Food and Drug Administration for new uses. Methods Here, we used breast cancer as a disease model and systematically proposed a new strategy based on multidimensional o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2a6f6d8d-fb14-5aba-92a9-8e58559fa510
DOI: 10.21203/rs.3.rs-26796/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Systematic identification of drug-based prognostic biomarkersby integrating multiomics in breast cancerDOI 10.21203/rs.3.rs-26796/v1Read

A network model for patient-derived drug response in breast cancer integrating multi-omics datasetsSemantic proximity Read

Deep learning based on multi-omics integration identifies potential therapeutic targets in breast cancerSemantic proximity Read

From multi-omics data to the cancer druggable gene discovery: a novel machine learning-based approachSemantic proximity Read

Construction of a prognostic model of purine metabolism-related genes for breast cancer and validation of key gene PAICSSemantic proximity Read

Detection of biomarkers related to the diagnosis and prognosis of breast cancer through the combination of gene expression profiling and DNA methylationSemantic proximity Read

Identification of a DNA Methylation-Driven Genes-Based Prognostic Model and Drug Targets in Breast Cancer: In silico Screening of Therapeutic Compounds and in vitro Characterization.Semantic proximity Read

Real-World Landscape of Genomic Medicine in Breast Cancer Revealed by the C-CAT Database: Reappraisal of Drug Accessibility and Clinical Utility in 6,307 PatientsSemantic proximity Read

Transcriptomic analysis revealed potential regulatory biomarkers and repurposable drugs for breast cancer treatmentSemantic proximity Read

MOLI: Multi-Omics Late Integration with deep neural networks for drug response predictionSemantic proximity Read

Multi-Omics Data Analysis Identifies Prognostic Biomarkers across CancersSemantic proximity Read

Identification and validation of a prognostic signature of drug resistance and mitochondrial energy metabolism-related differentially expressed genes for breast cancerSemantic proximity Read

Drug Repositioning Study in Search of Potent Inhibitors Blocking Multiple Pathways for the Treatment of Breast CancerSemantic proximity Read